Brief: Schott Pharma And Serum Institute Of India Welcome New Partner To Joint Venture In India Tpg Makes Strategic Investment In Schott Poonawalla
06/05/2025 06:04
May 6 (Reuters) - SCHOTT PHARMA AG & CO KGAA 1SXP.DE: SCHOTT PHARMA AND SERUM INSTITUTE OF INDIA WELCOME NEW PARTNER TO JOINT VENTURE IN INDIA; TPG MAKES STRATEGIC INVESTMENT IN SCHOTT POONAWALLA TPG, A LEADING GLOBAL ALTERNATIVE ASSET MANAGEMENT FIRM WILL ACQUIRE 35% STAKE IN SCHOTT POONAWALLA FROM SERUM INSTITUTE OF INDIA (SII) SII WILL RETAIN A MINORITY STAKE IN COMPANY, WITH SCHOTT PHARMA MAINTAINING 50% OWNERSHIP EXPECTED TO CLOSE WITHIN FIRST HALF OF 2025 Source text: ID:nEQ3Bym9ca Further company coverage: 1SXP.DE (Gdansk Newsroom) (((( gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))